802541-89-5

Basic information

• Product Name: N-(tert-butoxycarbonyl)-(1S)-1-methyl-2-morpholin-4-yl-2-oxo-1-phenylethylamine
• Synonyms: N-(tert-butoxycarbonyl)-(1S)-1-methyl-2-morpholin-4-yl-2-oxo-1-phenylethylamine
• CAS NO: 802541-89-5
• Molecular Weight: 334.415
• Mol File: 802541-89-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(tert-butoxycarbonyl)-(1S)-1-methyl-2-morpholin-4-yl-2-oxo-1-phenylethylamine(CAS DataBase Reference)
• NIST Chemistry Reference: N-(tert-butoxycarbonyl)-(1S)-1-methyl-2-morpholin-4-yl-2-oxo-1-phenylethylamine(802541-89-5)
• EPA Substance Registry System: N-(tert-butoxycarbonyl)-(1S)-1-methyl-2-morpholin-4-yl-2-oxo-1-phenylethylamine(802541-89-5)

Safety Data

• Hazardous Substances Data: 802541-89-5(Hazardous Substances Data)

Upstream product

• 13398-26-0 (S)-2-methyl-2-phenylglycine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 110-91-8 morpholine 
• 802541-88-4 N-(tert-butoxycarbonyl)-2-phenyl-D-alanine 

Downstream Products

• 802541-90-8 (1S)-1-methyl-2-morpholin-4-yl-2-oxo-1-phenylethylamine hydrochloride 

Relevant articles and documents

PYRAZOLO-QUINAZOLINE DERIVATIVES,PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS

Pyrazolo-quinazoline derivatives of formula (Ia) or (Ib) as defined in the specification, and pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.